HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

U Haberkorn Selected Research

(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)

6/2015SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.
3/2015Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy.
11/2014²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience.
6/2013Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy.
10/2012Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
7/2001PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


U Haberkorn Research Topics

Disease

17Neoplasms (Cancer)
06/2015 - 10/2000
9Neoplasm Metastasis (Metastasis)
06/2015 - 10/2000
6Experimental Liver Neoplasms
11/2001 - 01/2001
5Prostatic Neoplasms (Prostate Cancer)
11/2015 - 06/2012
4Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2015 - 10/2012
2Carcinoma (Carcinomatosis)
04/2013 - 05/2001
2Melanoma (Melanoma, Malignant)
01/2009 - 10/2000
2Hepatocellular Carcinoma (Hepatoma)
12/2001 - 11/2001
2Breast Neoplasms (Breast Cancer)
05/2001 - 01/2001
1Hypercalcemia (Milk Alkali Syndrome)
03/2013
1Hypercalciuria
03/2013
1Primary Hyperparathyroidism
03/2013
1Cicatrix (Scar)
04/2012
1Lymphoma (Lymphomas)
04/2012
1Anoxia (Hypoxia)
01/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2006
1Osteomalacia
02/2005
1Merkel Cell Carcinoma
06/2003
1Lung Neoplasms (Lung Cancer)
09/2001
1Colorectal Neoplasms (Colorectal Cancer)
09/2001
1Thyroid Neoplasms (Thyroid Cancer)
07/2001
1Neurilemmoma (Schwannoma)
07/2001
1Meningioma (Meningiomas)
07/2001
1Neurofibroma
07/2001
1Glioblastoma (Glioblastoma Multiforme)
06/2001
1Sarcoma (Soft Tissue Sarcoma)
05/2001
1Adenocarcinoma
11/2000
1Experimental Melanoma
10/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2000

Drug/Important Bio-Agent (IBA)

6(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
06/2015 - 07/2001
6Glucose (Dextrose)FDA LinkGeneric
10/2011 - 04/2001
5Somatostatin Receptors (Somatostatin Receptor)IBA
06/2015 - 11/2000
4GalliumIBA
06/2013 - 05/2001
4Thymidine KinaseIBA
12/2001 - 07/2001
3N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
11/2015 - 04/2013
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2015 - 06/2003
2Peptide Receptors (Peptide Receptor)IBA
06/2015 - 06/2013
2BenzamidesIBA
01/2009 - 10/2000
2AntibodiesIBA
04/2008 - 05/2001
2Octreotide (Sandostatin)FDA LinkGeneric
06/2003 - 07/2001
2Deoxyglucose (2 Deoxy D glucose)IBA
11/2001 - 01/2001
2hygromycin AIBA
02/2001 - 01/2001
1Urea (Carbamide)FDA LinkGeneric
11/2015
13-Tyr-octreotideIBA
06/2015
1Carbon MonoxideIBA
04/2013
1LigandsIBA
04/2013
1human glutamate carboxypeptidase IIIBA
04/2013
1Parathyroid Hormone (Parathormone)IBA
03/2013
1gadolinium ethoxybenzyl DTPAIBA
10/2012
1fluoroethylcholineIBA
06/2012
1ThymidineIBA
04/2012
1Biological Markers (Surrogate Marker)IBA
10/2011
1Serine (L-Serine)FDA Link
10/2011
1RadiopharmaceuticalsIBA
10/2011
1Proteins (Proteins, Gene)IBA
04/2008
1IonsIBA
03/2008
1Chelating AgentsIBA
03/2008
1NitroimidazolesIBA
01/2007
1cetuximab (Erbitux)FDA Link
01/2006
1Oncogenic osteomalaciaIBA
02/2005
1pentetreotide (OctreoScan)FDA Link
06/2003
1IndiumIBA
06/2003
1Ganciclovir (Cytovene)FDA LinkGeneric
12/2001
1MED 27IBA
12/2001
1Cytochalasin BIBA
11/2001
1enhanced green fluorescent proteinIBA
07/2001
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
07/2001
1fialuridineIBA
06/2001
1Acyclovir (Aciclovir)FDA LinkGeneric
06/2001
1anaplastic Thyroid cancerIBA
05/2001
1A-factor (Streptomyces)IBA
05/2001
1MucinsIBA
05/2001
1AntigensIBA
05/2001
1papillary Thyroid cancerIBA
05/2001
1NeomycinFDA LinkGeneric
05/2001
1gemcitabineFDA Link
04/2001
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2001
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
11/2000
1sigma Receptors (sigma Receptor)IBA
10/2000
1benzamideIBA
10/2000
1ropinirole (Requip)FDA LinkGeneric
04/2000
1pramipexol (pramipexole)FDA LinkGeneric
04/2000
1Dopamine Agonists (Dopamine Agonist)IBA
04/2000
1Acetylcysteine (Siran)FDA LinkGeneric
04/2000
1MelatoninIBA
04/2000
1flupirtineIBA
04/2000
1idebenoneIBA
04/2000

Therapy/Procedure

3Aftercare (After-Treatment)
12/2001 - 04/2001
1Intra-Arterial Infusions
11/2014
1Drug Therapy (Chemotherapy)
04/2012
1Radioimmunotherapy
04/2008
1Organ Transplantation
10/2001
1Intravenous Injections
07/2001
1Injections
05/2001
1Heterologous Transplantation (Xenotransplantation)
05/2001